Diagnosis and body mass index effects on hippocampal volumes and neurochemistry in bipolar disorder.

scientific article

Diagnosis and body mass index effects on hippocampal volumes and neurochemistry in bipolar disorder. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1084133428
P356DOI10.1038/TP.2017.42
P932PMC publication ID5404613
P698PubMed publication ID28350397

P50authorDonna J LangQ52146720
David J. BondQ52146724
William G. HonerQ67517593
Raymond W. LamQ42883552
P2093author name stringL N Yatham
I J Torres
W Su
E L MacMillan
L E Silveira
P2860cites workRelationship between body mass index and hippocampal glutamate/glutamine in bipolar disorder.Q52146674
Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder - A combined magnetic resonance imaging and positron emission tomography study.Q52149761
Neuroinflammation in bipolar disorder - A [(11)C]-(R)-PK11195 positron emission tomography study.Q53071540
The Association of Elevated Body Mass Index with Reduced Brain Volumes in First-Episode ManiaQ59488864
Body mass index and the risk of Parkinson diseaseQ59542870
Correlates of overweight and obesity in 644 patients with bipolar disorderQ60646356
Bidirectional transport of interleukin-1 alpha across the blood-brain barrierQ69425218
Prevalence of diabetes in a manic-depressive populationQ71263887
Estimation of metabolite concentrations from localized in vivo proton NMR spectraQ72319396
Increased risk of hypertension in patients with bipolar disorder and patients with anxiety compared to background population and patients with schizophreniaQ79731969
Increased amygdalar and hippocampal volumes in elderly obese individuals with or at risk of cardiovascular diseaseQ83750526
Medical comorbidity in women and men with bipolar disorders: a population-based controlled study.Q50475369
Increased body mass index makes an impact on brain white-matter integrity in adults with remitted first-episode mania.Q50706849
Body size and risk of MS in two cohorts of US womenQ22241653
Environmental, life-style, and physical precursors of clinical Parkinson?s disease: recent findings from the Honolulu-Asia Aging StudyQ23920249
From inflammation to sickness and depression: when the immune system subjugates the brainQ24633527
Caloric restriction delays disease onset and mortality in rhesus monkeysQ24655994
A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future researchQ27027438
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.Q27860879
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceQ28131660
Localisation of N-acetylaspartate in oligodendrocytes/myelinQ28304873
Advances in functional and structural MR image analysis and implementation as FSLQ29547164
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10Q29547745
Protection from obesity-induced insulin resistance in mice lacking TNF-alpha functionQ29616104
The reward circuit: linking primate anatomy and human imagingQ29619828
Adipokines in inflammation and metabolic diseaseQ29620456
A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectraQ30698264
Hippocampal structure and function in individuals with bipolar disorder: a systematic reviewQ30877471
Bimodal effect of lithium plasma levels on hippocampal glutamate concentrations in bipolar II depression: a pilot studyQ30880781
Human emotion and memory: interactions of the amygdala and hippocampal complexQ30921275
Proton echo-planar spectroscopic imaging of J-coupled resonances in human brain at 3 and 4 TeslaQ31117667
N-acetylaspartate in the vertebrate brain: metabolism and functionQ33186840
Bayesian analysis of neuroimaging data in FSL.Q33390048
Course and outcome after the first manic episode in patients with bipolar disorder: prospective 12-month data from the Systematic Treatment Optimization Program For Early Mania projectQ33414015
The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysisQ33422129
Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient dataQ33732384
BMI and neuronal integrity in healthy, cognitively normal elderly: a proton magnetic resonance spectroscopy studyQ33759530
Impact of overweight on the risk of developing common chronic diseases during a 10-year periodQ33843923
Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a reviewQ33870787
Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy studyQ33908187
A potential role for adiponectin receptor 2 (AdipoR2) in the regulation of alcohol intakeQ34003624
A common mechanism of action for three mood-stabilizing drugsQ34128871
MR spectroscopic studies of the brain in psychiatric disordersQ34147260
Human cognitive function and the obesogenic environment.Q34167761
Prevalence of obesity and weight change during treatment in patients with bipolar I disorderQ43642752
High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and womenQ43865774
Algebraic T2 estimation improves detection of right temporal lobe epilepsy by MR T2 relaxometry.Q43876986
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.Q44142664
Obesity as a correlate of outcome in patients with bipolar I disorderQ44265285
Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patientsQ44323569
Lower Concentration of HippocampalN-Acetylaspartate in Familial Bipolar I DisorderQ44427291
Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imagingQ44438240
Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization databaseQ44608499
Abdominal obesity and lower gray matter volume: a Mendelian randomization studyQ45156972
Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy studyQ46040518
1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patientsQ46429555
Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjectsQ46505854
Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisolQ46696102
Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for PennsylvaniansQ46714706
Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorderQ46756223
Neurochemical pathology in hippocampus in euthymic patients with bipolar I disorderQ46800649
Elevated frequency of diabetes mellitus in hospitalized manic-depressive patientsQ48114087
Similarities of biochemical abnormalities between major depressive disorder and bipolar depression: a proton magnetic resonance spectroscopy studyQ48236855
Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapineQ48374943
Hippocampal 1H MRS in first-episode bipolar I patientsQ48521859
Association between hippocampal volume and serum adiponectin in patients with type 2 diabetes mellitusQ48621677
Intravenous human interleukin-1alpha impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septumQ48743563
Body mass index-related regional gray and white matter volume reductions in first-episode mania patients.Q48938681
(1)H-MRS of hippocampus in patients after first manic episodeQ49106947
A pathophysiological framework of hippocampal dysfunction in ageing and diseaseQ34214060
Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysisQ34352492
Leptin is associated with exaggerated brain reward and emotion responses to food images in adolescent obesityQ34392344
Physical exercise-induced hippocampal neurogenesis and antidepressant effects are mediated by the adipocyte hormone adiponectinQ34444287
Obesity-mediated inflammation may damage the brain circuit that regulates food intakeQ34520842
Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use.Q34735182
Immune system to brain signaling: neuropsychopharmacological implications.Q34769827
Brain inflammation is induced by co-morbidities and risk factors for strokeQ35132428
The burden of obesity among adults with bipolar disorder in the United StatesQ35167517
Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosisQ35204725
Cluster analysis reveals abnormal hippocampal neurometabolic profiles in young people with mood disorders.Q35583037
Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate systemQ35723798
Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre studyQ35925666
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversiesQ36161335
Leptin, abdominal obesity, and onset of depression in older men and womenQ36364473
Leptin: a diverse regulator of neuronal functionQ36640453
Leptin increases adult hippocampal neurogenesis in vivo and in vitroQ36737548
Functions and effects of creatine in the central nervous system.Q37172733
Dietary composition modulates brain mass and solubilizable Abeta levels in a mouse model of aggressive Alzheimer's amyloid pathologyQ37417661
Adiponectin protects hippocampal neurons against kainic acid-induced excitotoxicityQ37491529
Inter-relationships among diet, obesity and hippocampal-dependent cognitive function.Q37603549
Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorderQ37607009
Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies.Q37846798
Leptin and the brain: influences on brain development, cognitive functioning and psychiatric disorders.Q38236965
Obesity-induced cerebral hypoperfusion derived from endothelial dysfunction: one of the risk factors for Alzheimer's diseaseQ38248455
Adipocyte dysfunction, inflammation and metabolic syndromeQ38262628
The trouble with quality filtering based on relative Cramér-Rao lower boundsQ38370857
Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implicationsQ38885804
Child overweight and obesity are associated with reduced executive cognitive performance and brain alterations: a magnetic resonance imaging study in Mexican children.Q38897258
Association between waist circumference and gray matter volume in 2344 individuals from two adult community-based samples.Q38976095
Association of leptin with food cue-induced activation in human reward pathwaysQ39620178
Hippocampal glutamatergic/NMDA receptor functioning in bipolar disorder: A study combining mismatch negativity and proton magnetic resonance spectroscopyQ40839445
Being overweight is associated with hippocampal atrophy: the PATH Through Life Study.Q41695395
Altered neurochemical ingredient of hippocampus in patients with bipolar depressionQ42131600
Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept studyQ42638564
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue3
P921main subjectbipolar disorderQ131755
neurochemistryQ786278
P304page(s)e1071
P577publication date2017-03-28
P1433published inTranslational PsychiatryQ15716636
P1476titleDiagnosis and body mass index effects on hippocampal volumes and neurochemistry in bipolar disorder
P478volume7

Reverse relations

cites work (P2860)
Q47549322Brain Structure and Function in Women with Comorbid Bipolar and Premenstrual Dysphoric Disorder.
Q64964969Examining Patterns of Polypharmacy in Bipolar Disorder: Findings from the REAP-BD, Korea.
Q57454956Neurococognitive and neuroimaging correlates of obesity and components of metabolic syndrome in bipolar disorder: a systematic review

Search more.